NI-0801
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NI-0801, covering 2010-11-19 to 2014-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody [Phase 2]